Loading clinical trials...

Clinical Trial to Evaluate the Efficacy and Safety of DWKH | Clinical Trials | Clareo Health

COMPLETEDPHASE3

Clinical Trial to Evaluate the Efficacy and Safety of DWKH

Phase III Clinical Trial to Evaluate the Efficacy and Safety of DWKH

NCT05683951•Daewon Pharmaceutical Co., Ltd.

View on ClinicalTrials.gov

Summary

Randomized, Double-blind, Parellel, Multicenter, Active-controlled

Eligibility

Age

19 - 80 years

Sex

ALL

Healthy Volunteers

Inclusion Criteria

•Male and female aged between 19 and 80.
•Patients whose BSS score is over 5.

Exclusion Criteria

•Patients allergic to any ingredients of the study drugs.
•Moderate liver disease (ALT or AST \> UNLx3).
•Moderate lung disease.
•Uncontrolled HTN.
•Uncontrolled DM.
•Uncontrolled thyroidism.
•Patients who is needed antibiotics during the study period.
•In the case of women, pregnant(Urine-HCG positive) or lactating women.

Locations (1)

Korea University Guro Hospital

Seoul, South Korea

Key Dates

Start Date

November 26, 2021

Primary Completion Date

December 9, 2022

Completion Date

December 16, 2022

Last Updated

January 13, 2023

Enrollment

186

ACTUAL participants

Conditions

Respiratory Infection

Interventions

DWKH

DRUG

DWKH-R

DRUG

Placebo

DRUG

Effectiveness and Implementation of a National Guideline for Acute Respiratory Tract Infections to Reduce Antibiotic Prescribing in Swiss Primary Care

NCT07396428

Acute Respiratory InfectionInfluenza-like Illness

View study

RECRUITING

The Fever Clinic Acute Respiratory Cohort

NCT07278700

Acute Respiratory InfectionsFebrile Illnesses+3 more

View study

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: January 13, 2023Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

Clinical Trial to Evaluate the Efficacy and Safety of DWKH

Inclusion Criteria

Exclusion Criteria

Effectiveness and Implementation of a National Guideline for Acute Respiratory Tract Infections to Reduce Antibiotic Prescribing in Swiss Primary Care

The Fever Clinic Acute Respiratory Cohort

FebriDx® Pediatric Validation Study

Impact of the Presence of Anti-interferon Autoantibodies on the Viral Load in Severe Respiratory Infections

Omalizumab Before Onset of Exacerbations

Study of the Safety, Tolerability, and Pharmacokinetic Profile of Ascending Doses of Ingavirin Forte, Capsules, Folliwing Single and Subsequent Multiple Oral Administration in Healthy Volunteers